Medicine and Health Sciences Commons^™

Oncology, Volume 56, Number 08, August 2011, Stephanie Deming, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

• Addressing the Cardiac Complications of Cancer Treatment: Patients with cancer surviving longer than ever after treatment, and new targeted therapy agents are being introduced into the clinic with increasing frequency. These advances are cause for optimism, but they have also led to an increased incidence of cardiac complications of cancer therapy
• Compass: Early- and Intermediate-Stage Gastric Cancer: Neoadjuvant of adjuvant treatments offer higher cure rates than surgery alone
• HOUSE CALL: Managing Disease-Related Fatigue- Patients and doctors offer can make fatigue less severe

Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman

OncoLog MD Anderson's Report to Physicians (All issues)

• MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
• Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients

Early Toxicity Predicts Long-Term Survival In High-Grade Glioma., Y. R. Lawrence, M Wang, Adam Dicker, David W Andrews, Walter J Curran, J M Michalski, L Souhami, W-Ka Yung, M Mehta

Department of Radiation Oncology Faculty Papers

BACKGROUND: Patients with high-grade gliomas are treated with surgery followed by chemoradiation. The risk factors and implications of neurological side effects are not known.

METHODS: Acute and late ≥ grade 3 neurological toxicities (NTs) were analysed among 2761 patients from 14 RTOG trials accrued from 1983 to 2003. The association between acute and late toxicity was analysed using a stepwise logistic regression model. The association between the occurrence of acute NT and survival was analysed as an independent variable.

RESULTS: There were 2610 analysable patients (86% glioblastoma, 10% anaplastic astrocytoma). All received a systemic agent during radiation (83% chemotherapy, 17% …

Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

• Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
• Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
• MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
• HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines …

Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

• Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
• Screen Guidelines in Brief
• Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
• House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
• in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression